Analysed NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) News Sources
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
15-04-2026
yahoo.com
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
28-04-2026
yahoo.com
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
12-05-2026
yahoo.com
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...
12-05-2026
yahoo.com
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
22-05-2026
yahoo.com
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
28-05-2026
yahoo.com
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
08-06-2026
yahoo.com
What is the current price of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The current price of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is $3.25.
NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) since the previous trading day is $-0.07.
NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) since the previous trading day is -2.1084%.
What is the most recent average sentiment score for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The most recent average sentiment score for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)?
The most recent sentiment for NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ) is .
SEC-8K** Filing Available For NEUROONE MEDICAL TECHNOLOGIE (NMTC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.